-O-C-C) 43 Bisocodyt Bisoxatin with -gIucuronidase and subsequent column extraction. The procedure is very sensitive: at least 32 h after a single dose of bisacodyl, danthron, phenolphthalein, or sennoside, the drug can be detected in the urine. Bisoxatin and oxyphenisatin are still detectable in the urine 18 h after intake. The method is also highly specific; none of 73 other drugs interfered in either of the two chromatographic systems. This procedure can be helpful for the early diagnosis of laxative abuse.
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Self-administration
of laxatives is a common cause of drug-induced disease (1) (2) (3) (4) (5) . Individuals taking self-prescribed laxatives regularly in the belief that daily evacuation of the bowel is obligatory for survival, may eventually develop a wide range of complaints such as diarrhea, abdominal pain, hypokalemia, characteristic radiological phenomena ("cathartic colon") (1, 6) , or even anorexia nervosa (7) , and, in the case of oxyphenisatin, cirrhosis of the liver (8) . Child abuse by emotionally disturbed mothers in the form of chronic administration of laxatives has also been described (9) .
The pharmacological group of laxatives is usually divided into four categories: stool softeners, osmotic laxatives, bulk laxatives, and stimulants (10) . Of all the laxatives, the stimulants, irritants, or cathartics are the most abused by the public (4). Methods for identification of bisacodyl and anthraquinone derivatives have been described (11) (12) (13) , but since there was no screening method for the detection of this category of drugs in general in the literature, we developed a procedure covering the six active principles (Figure 1) , which represent about 90% of all colonic stimulants available in The Netherlands. Our method is based on high-performance thin-layer chromatography of a urine sample pretreated with $-D-glucuronidase (EC 3.2.1.31) and subjected to column extraction. 
Materials and Methods

Drugs and Reagents
Reference Solutions
Reference solutions of danthron and rhein are prepared by dissolving 2 mg of either drug in 10 mL of chloroform. Phenolphthalein (2 mg) is first dissolved in 1 mL of ethanol, then diluted to 10 mL with chloroform.
Reference solutions of bisacodyl, bisoxatin, and oxyphenisatin and their hydrolysis products are prepared by dissolving 2 mg of each substance in 2 mL of ethanol to which 20 ML of NaOH solution (6 molfL) is added. After heating for 30 mm at 70#{176}C, the contents of the tubes are cooled and neutralized with 20 ML of HC1 (6 mol/L), and 8 mL of chloroform is added. Then, 2 mg of each native substance is dissolved in the cor- 
Studies in Volunteers
Six healthy volunteers, ages between 22 and 36 years, all staff members of this laboratory, took one of the six investigated laxatives in the lowest commercially available dosage form (except for sennoside A + B, of which two 12-mg tablets were taken, and for oxyphenisatin, of which two 5-mg capsules were swallowed) at 2300 hours. Urine specimens were collected after 8, 18, and 32 h, and also samples of the first two stools after drug intake ( Table 2) .
Feces samples the size of a pea were suspended in 3 mL of the acetate buffer (pH 5.0) and treated in the same way as urine, except that the Ketodase step was omitted and Extube#{174} Clin Elut extraction columns (type CE 1003) were used.
Procedure
Extraction.
To a 20-mL aliquot of 24-h urine add 2 mL of the acetate buffer and 1 mL of Ketodase. Heat in a water bath for 2 h at 60 #{176}C. Pour into a Tox Elut column and wait 3 mm.
Then pour 20 mL of the chloroform-isopropanol extraction mixture into the column and collect the effluent in a reagent tube, evaporate it under a stream of filtered nitrogen in a water bath set at 40 #{176}C, and dissolve the residue in 100 1zL of chloroform just before applying the solution to the thin-layer plate.
Thin-layer chromatography.
Mark two chromatographic
plates as indicated in Figure 2A and B. Place the plates on a hot plate at 60 #{176}C and apply 5 ML of the reference solutions on the concentration zone at the appropriate sites. Apply the urine extract in two amounts: one spot of 3 ML and one of 10 ILL.
Develop the plates at ambient temperature in solvent-saturated 10-cm high chambers until the front reaches the 5-cm 
Results and DiscussIon
Optimization of Analytical Conditions
The necessity for Ketodase treatment of the urine was studiedwith bisacodyl and phenolphthalein.
If this step is omitted, little or no drug can be detected in the urine. We compared the "classical" conditions for Ketodase treatment (overnight at 37 #{176}C) with the more drastic, but time-saving, 2-h hydrolysis at 60 eC, and found no difference in sensitivity between these two conditions.
The lowest detectable absolute amount was established (Table 1) by applying 50, 100, 500, and 1000 ng of each drug to a thin-layer plate, inspecting after chromatography, and spraying with the appropriate reagent. We also studied the effect of urine background in visual detection of the laxatives by extraction from drug-supplemented Ketodase-treated blank urine followed by chromatography, but the results did not differ significantly from those obtained with the former method. This finding also suggests satisfactory extraction recovery of these drugs by the latter method.
The pH optimum for extraction was determined by adding 5ig of each drug per milliliter to different buffers at pH 4,5, 7, or 9, and subsequent extraction and chromatography. For bisacodyl, bisoxatin, and phenolphthalein, no effect of pH on the extraction was found. Oxyphenisatin hydrolyzes at pH 9. Extraction of danthron was optimal at pH 7, and that of rhein at pH 5. Because the dose and urinary concentration of danthron are sufficiently high to make it impossible to miss danthron intake, even when extraction is performed at a suboptimal pH, we chose a pH value of 5. This has the additional advantage of also being the optimal pH value for Ketodase treatment.
Use of the extraction mixture dichloromethane + isopro- 1 by vol). The chloroform + isopropanol mixture was found to be superior to the others for our purpose. We tried to find one eluent giving satisfactory chromatographic separation of all laxatives and their metabolites, but the polarity of rhein made it necessary to introduce a second chromatographic plate and eluent. This is not a great disadvantage, because both plates can be treated simultaneously and the second plate gives additional information about bisoxatin, danthron, and phenolphthalein.
Possible interference by other drugs was tested in both thin-layer chromatography systems by spotting 5 g of 73 commonly used drugs, followed by chromatography and spraying. These drugs are listed in Table 3 in alphabetical order according to their generic name. None caused any interference with the identification of the laxatives.
Observations in Subjects and Patients
The results obtained in volunteers are summarized in Table
The reference solution of bisacodyl shows two spots, the higher being unchanged bisacodyl, and the other most probably the dihydroxy compound. In stool, unchanged bisacodyl can be found; in urine, only the lower of the two (purple) spots is seen, together with an unknown metabolite at RF 0.59 relative to phenolphthalein that is also colored purple with NaOH. Bisacodyl could be detected in a urine sample collected 32 h after intake of a single 5-mg dose.
Unchanged bisoxantin is found in neither urine nor stool.
The hydrolysis product is present in both. After a single 60-mg dose, bisoxatin could be found in a urine sample collected 18 h after intake, but not in one obtained after 32 h. Danthron is the most easily detected laxative of the series. It appears unchanged in urine and feces in high concentrations, and has characteristic fluorescence and coloring properties. It can be detected in a urine sample 32 h after intake, and probably even later. Oxyphenisatin poses a special problem. color pink after spraying with NaOH, but the color intensity is too weak to identify this drug in urine extracts. Spraying with potassium ferricyanide-which turns the color to purple-is therefore necessary. Unchanged oxyphenisatmn in a urine extract is hardly visible; the second hydrolysis product is clearly visible 8 h after ingestion of 10 mg, and less clearly in a urine specimen collected at 18 h. In addition, a spot with an RF of 0.37 relative to phenolphthalein and which colors bluish-purple with NaOH and potassium ferricyanide spray is seen, even in subjects taking 5 mg of oxyphenisatin, as much as 32 h after drug ingestion. It is not unlikely that this spot represents an unknown metabolite of oxyphenisatin.
In stool, neither unchanged oxyphenisatin not its hydrolysis products can be identified, suggesting extensive absorption. In those countries where oxyphenisatin is banned because of its hepatotoxicity, this step can be omitted. Phenolphthalein is easily detected in unchanged form, both in urine up to 32 h after intake, and in stool.
Rhein, a metabolite of many vegetable laxatives such as senna, aloe, rhubarb, or cascara (13), can be detected after intake of 24 mg of sennoside A + B, and it seems highly probable that even when taken in a dose of 12 mg, rhein can be found in urine 32 h after intake. In stool, no rhein was found after sennoside intake. The urine of a volunteer who had consumed a large meal of stewed rhubarb showed no rhein, which demonstrates that this vegetable does not interfere with the laxative test. We were unable to visualize sodium picosulfate in our chromatographic systems, either as the pure substance or in metabolized form after treatment of urine and stool of a volunteer who took this colonic stimulant.
This means that ingestion of laxatives containing sodium picosulfate as the active principle cannot be detected with the present method.
After this procedure had been introduced in our laboratory, 46 patients who were suspected of laxative abuse were seen in the course of 20 months. In the urine of six of these patients we were able to detect bisacodyl, and two patients' urines were positive for senna.
Generally,
we advise the clinician to collect urine for laxative analysis on three successive days, which gives a better chance of "catching" a laxative abuser.
In conclusion, we have designed a simple, sensitive method for detection of most of the commercially available colonic stimulants. Although it is generally believed that these locally acting drugs are hardly absorbed from the gastrointestinal tract, the degree of absorption is apparently sufficient to permit detection of these drugs in the urine, in most cases as long as 32 h after intake of a single dose. This offers the advantage that analysis can be restricted to urine, which is much easier to handle and gives much better results than feces, in screening for laxative abuse.
